Vetr Top Raters Upgrade Vital Therapies To 5-Star Stock

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Shares of Vital Therapies Inc

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NASDAQ: VTL), a a biotherapeutic company that focuses on treatment for all forms of acute liver failure, have lost more than 60 percent over the past year, likely prompting Vetr top raters to take advantage of the recent weakness.Vetr top raters upgraded Vital Therapies' stock rating to a 5-star out of 5 rating. In fact, shares of Vital Therapies have risen to $7.82 since the prior rating of 3.5-stars was issued just 3 days ago.Related link:

Here's how crowdsourced ratings can beat the market.Despite a 5-star out of 5-star rating, Vital Therapies isn't a popular name as less than 2 percent of Vetr users are holding Vital Therapies' stock in their watch-lists. Meanwhile, 62 percent of the crowd's ratings are bullish and the crowd sourced price target of $9.28 implies an upside just shy of 20 percent.